International Assets Investment Management LLC purchased a new position in shares of BlackRock Health Sciences Trust (NYSE:BME – Free Report) in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 20,532 shares of the company’s stock, valued at approximately $8,610,000.
A number of other hedge funds and other institutional investors also recently modified their holdings of BME. Logan Stone Capital LLC purchased a new position in BlackRock Health Sciences Trust during the 2nd quarter valued at about $600,000. City of London Investment Management Co. Ltd. bought a new position in BlackRock Health Sciences Trust in the 2nd quarter valued at approximately $429,000. Wolverine Asset Management LLC lifted its position in BlackRock Health Sciences Trust by 360.1% in the 2nd quarter. Wolverine Asset Management LLC now owns 60,108 shares of the company’s stock valued at $2,455,000 after acquiring an additional 47,044 shares in the last quarter. Consolidated Portfolio Review Corp lifted its position in BlackRock Health Sciences Trust by 133.8% in the 2nd quarter. Consolidated Portfolio Review Corp now owns 39,721 shares of the company’s stock valued at $1,623,000 after acquiring an additional 22,729 shares in the last quarter. Finally, Cambridge Investment Research Advisors Inc. lifted its position in BlackRock Health Sciences Trust by 4.3% in the 2nd quarter. Cambridge Investment Research Advisors Inc. now owns 54,605 shares of the company’s stock valued at $2,231,000 after acquiring an additional 2,240 shares in the last quarter.
BlackRock Health Sciences Trust Price Performance
NYSE BME opened at $39.93 on Friday. The business’s fifty day moving average price is $41.69 and its 200-day moving average price is $40.82. BlackRock Health Sciences Trust has a 1-year low of $35.92 and a 1-year high of $42.86.
BlackRock Health Sciences Trust Dividend Announcement
BlackRock Health Sciences Trust Profile
BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, supplies, equipment, or services.
See Also
- Five stocks we like better than BlackRock Health Sciences Trust
- Bank Stocks – Best Bank Stocks to Invest In
- Microsoft Can Hit New All-Time Highs This Year – Here’s Why
- Business Services Stocks Investing
- Zillow Stock’s Bull Case: Why This Recent Sell-Off Could Be a Buy
- Top Stocks Investing in 5G Technology
- IonQ’s Quantum Surge: Ride the Wave or Cash Out?
Want to see what other hedge funds are holding BME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for BlackRock Health Sciences Trust (NYSE:BME – Free Report).
Receive News & Ratings for BlackRock Health Sciences Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Health Sciences Trust and related companies with MarketBeat.com's FREE daily email newsletter.